logo

CARE

Carter Bankshares·NASDAQ
--
--(--)
--
--(--)
5.40 / 10
Netural

The firm exhibits average fundamental strength scoring 5.4/10. Supportive aspects: Revenue-MV and Current assets turnover ratio, despite concerns regarding Profit-MV. Investment verdict: moderate.

Fundamental(5.4)SentimentTechnical

Analysis Checks(9/10)

Revenue-MV
Value-0.61
Score2/3
Weight11.16%
1M Return5.14%
Gross profit margin (%)
Value35.31
Score3/3
Weight7.16%
1M Return3.33%
Profit-MV
Value0.96
Score1/3
Weight9.67%
1M Return4.10%
Net income-Revenue
Value0.20
Score3/3
Weight15.92%
1M Return6.64%
PB-ROE
Value-0.96
Score3/3
Weight14.81%
1M Return6.32%
Total profit (YoY growth rate %)
Value29.58
Score3/3
Weight9.58%
1M Return4.25%
Non-current liabilities / Total liabilities (%)
Value52.31
Score3/3
Weight7.16%
1M Return3.33%
Total profit / EBIT (%)
Value100.00
Score3/3
Weight7.16%
1M Return3.33%
Current assets turnover ratio
Value2.32
Score3/3
Weight7.19%
1M Return3.34%
Cash-UP
Value-0.28
Score2/3
Weight10.21%
1M Return4.61%
Is CARE undervalued or overvalued?
  • CARE scores 5.40/10 on fundamentals and holds a Fair valuation at present. Backed by its 7.80% ROE, 20.47% net margin, 16.54 P/E ratio, 1.24 P/B ratio, and 30.19% earnings growth, these metrics solidify its Netural investment rating.